Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giuseppe Mangialardi

Showing results (1-10 of 32) with videos related to

Pageof 4
Sort By:
Current Diabetes Reports|March 31, 2016
Bone Marrow-Derived Stem Cells: a Mixed Blessing in the Multifaceted World of Diabetic ComplicationsGiuseppe Mangialardi, Paolo Madeddu
Heart (British Cardiac Society)|July 29, 2016
New vascular endothelial growth factor isoforms promise to increase myocardial perfusion without stealingGiuseppe Mangialardi, Paolo Madeddu
Current Cancer Drug Targets|July 12, 2012
Antiangiogenic therapeutic approaches in multiple myelomaDomenico Ribatti, Giuseppe Mangialardi, Angelo Vacca
Regenerative Medicine|November 26, 2016
The bone marrow pericyte: an orchestrator of vascular nicheGiuseppe Mangialardi, Andrea Cordaro, Paolo Madeddu
Antioxidants & Redox Signaling|August 5, 2014
Reactive oxygen species adversely impacts bone marrow microenvironment in diabetesGiuseppe Mangialardi, Gaia Spinetti, Carlotta Reni, et al.
Endocrine, Metabolic & Immune Disorders Drug Targets|January 13, 2012
Bone marrow microenvironment: a newly recognized target for diabetes-induced cellular damageGiuseppe Mangialardi, Atsuhiko Oikawa, Carlotta Reni, et al.
Diabetes|July 25, 2015
Enhancing Stem Cell Mobility: New Hope for Treatment of Cardiovascular Complications in Patients With Diabetes?Gaia Spinetti, Giuseppe Mangialardi, Claudia Specchia, et al.
Scientific Reports|July 30, 2016
Diabetes Stimulates Osteoclastogenesis by Acidosis-Induced Activation of Transient Receptor Potential Cation ChannelsCarlotta Reni, Giuseppe Mangialardi, Marco Meloni, et al.
Pharmacology & Therapeutics|December 6, 2016
Pericytes, an overlooked player in vascular pathobiologyDavid Ferland-McCollough, Sadie Slater, Jai Richard, et al.
International Journal of Clinical and Experimental Medicine|December 14, 2012
A retrospective study of skeletal and disease-free survival benefits of zoledronic acid therapy in patients with multiple myeloma treated with novel agentsRoberto Ria, Antonia Reale, Michele Moschetta, et al.
Pageof 4

Showing results (1-10 of 32) with videos related to

Sort By:
Pageof 4
Current Diabetes Reports|March 31, 2016
Bone Marrow-Derived Stem Cells: a Mixed Blessing in the Multifaceted World of Diabetic ComplicationsGiuseppe Mangialardi, Paolo Madeddu
Heart (British Cardiac Society)|July 29, 2016
New vascular endothelial growth factor isoforms promise to increase myocardial perfusion without stealingGiuseppe Mangialardi, Paolo Madeddu
Current Cancer Drug Targets|July 12, 2012
Antiangiogenic therapeutic approaches in multiple myelomaDomenico Ribatti, Giuseppe Mangialardi, Angelo Vacca
Regenerative Medicine|November 26, 2016
The bone marrow pericyte: an orchestrator of vascular nicheGiuseppe Mangialardi, Andrea Cordaro, Paolo Madeddu
Antioxidants & Redox Signaling|August 5, 2014
Reactive oxygen species adversely impacts bone marrow microenvironment in diabetesGiuseppe Mangialardi, Gaia Spinetti, Carlotta Reni, et al.
Endocrine, Metabolic & Immune Disorders Drug Targets|January 13, 2012
Bone marrow microenvironment: a newly recognized target for diabetes-induced cellular damageGiuseppe Mangialardi, Atsuhiko Oikawa, Carlotta Reni, et al.
Diabetes|July 25, 2015
Enhancing Stem Cell Mobility: New Hope for Treatment of Cardiovascular Complications in Patients With Diabetes?Gaia Spinetti, Giuseppe Mangialardi, Claudia Specchia, et al.
Scientific Reports|July 30, 2016
Diabetes Stimulates Osteoclastogenesis by Acidosis-Induced Activation of Transient Receptor Potential Cation ChannelsCarlotta Reni, Giuseppe Mangialardi, Marco Meloni, et al.
Pharmacology & Therapeutics|December 6, 2016
Pericytes, an overlooked player in vascular pathobiologyDavid Ferland-McCollough, Sadie Slater, Jai Richard, et al.
International Journal of Clinical and Experimental Medicine|December 14, 2012
A retrospective study of skeletal and disease-free survival benefits of zoledronic acid therapy in patients with multiple myeloma treated with novel agentsRoberto Ria, Antonia Reale, Michele Moschetta, et al.
Pageof 4